Scarlet Therapeutics
PrivateLast Round
Seed
May 7, 2026
Total Funding Raised
$4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Scarlet Therapeutics is a biotechnology company developing a platform for generating therapeutic red blood cell (tRBC) therapies to treat rare metabolic diseases, cancer, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scarlet Therapeutics Comparables
Compare Scarlet Therapeutics with similar companies based on industry and business-model similarity.
Scarlet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 7, 2026 | ||||
| Pre Seed | May 23, 2023 |
Key People
Founding team and executive leadership
Scarlet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oshen Holdings SA | Seed |
| SCVC | Seed |
| Meltwind Advisory | Pre Seed |
| Daft Capital | Seed |
| Science Creates Ventures | Seed, Pre Seed |
| Eos Advisory | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
$4M round led by Eos Advisory.
- Nov 9, 2025
Monthly visitors grew 108% MoM.
Recent news
Latest coverage and updates
- partners_withSep 23, 2026
Scarlet Therapeutics Limited partners with Unicorn Biotechnologies Ltd..
- partners_withSep 23, 2026
Scarlet Therapeutics Limited partners with Northwestern University.
- partners_withSep 23, 2026
Scarlet Therapeutics Limited partners with Bristol Old Vic Company.
- partners_withSep 23, 2026
Scarlet Therapeutics Limited partnered with Defense Advanced Research Projects Agency on Sep 23rd '26.
- is_developingSep 23, 2026
Scarlet Therapeutics Limited is developing adaptive smart red blood cells on Sep 23rd '26.
Scarlet Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Scarlet Therapeutics's valuation, stock price, and market status.
Is Scarlet Therapeutics a public or private company?
Scarlet Therapeutics is a private company.
What is the current stock price of Scarlet Therapeutics?
Scarlet Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Scarlet Therapeutics worth (valuation)?
Valuation information for Scarlet Therapeutics is not publicly available.
Can I buy Scarlet Therapeutics stock?
Scarlet Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Scarlet Therapeutics's last funding round?
Scarlet Therapeutics's most recent funding round was Seed on May 7, 2026.
Who are the main investors in Scarlet Therapeutics?
Key investors in Scarlet Therapeutics include Meltwind Advisory, Science Creates Ventures, Eos Advisory.
Will Scarlet Therapeutics IPO soon?
No public IPO plans have been announced for Scarlet Therapeutics.
How can I track Scarlet Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scarlet Therapeutics's secondary market activity and sign up for updates.